Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04429321
Title Nivolumab + Ipilimumab With Immunostimulatory Embolization for Stage 4 Renal Cell Carcinoma With Unresected Primary
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Pennsylvania
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.